1 Increasing Adoption of Targeted Therapy Over Traditional Therapy 2 Emergence of Biosimilars 3 Increasing Demand for Mabs 4 High Prevalence Rate of Lifestyle Diseases 5 Fast Track and Orphan Drug Designations
Viral vectors are modified viruses developed using sophisticated DNA recombination techniques. This alteration makes the viruses safe for the transfer of genes of interest to target cells or tissues for therapeutic purposes. Various types of viruses (e.g., adenoviruses, retroviruses, poxviruses, adeno-associated viruses and herpes simplex viruses) are currently being investigated for their potential in gene therapy.